Results 251 to 260 of about 84,335 (338)

Thrombus Composition and the Evolving Role of Tenecteplase in Acute Ischemic Stroke. [PDF]

J Clin Med
Frol S, Zupan M.
europepmc   +1 more source

Pathogen-reduced plasma, cryoprecipitate reduced for therapeutic plasma exchange. [PDF]

Transfusion
Tupin F, Mouriaux C, Hechler B, Kaastrup K, Yegneswaran S, Corash L, Mangin PH.   +6 more
europepmc   +1 more source

Proteinases and their inihibitors in septicemia [PDF]

, 1984
Duswald, Karl-Heimo, Fritz, Hans, Hörl, W. H., Jochum, Marianne, Neumann, S., Witte, J.   +5 more
core  

Profibrinolytic Factors and Cancer Progression, Metastasis, and Survival. [PDF]

Arterioscler Thromb Vasc Biol
Hisada Y, Mackman N.
europepmc   +1 more source

Plasmin-mediated proteolysis of von Willebrand factor in patients with acute and chronic liver disease. [PDF]

Res Pract Thromb Haemost
El Otmani H, Stamouli M, Adelmeijer J, Bernal W, Maas C, Patel VC, Lisman T.   +6 more
europepmc   +1 more source

SARS-CoV-2 Spike Protein Amyloid Fibrils Impair Fibrin Formation and Fibrinolysis. [PDF]

Biochemistry
Westman H, Hammarström P, Nyström S.
europepmc   +1 more source

Stealth hemostatic anchors with vWF-driven navigation and plasmin-triggered tranexamic release for hematoma containment in cerebral hemorrhage. [PDF]

Asian J Pharm Sci
Wang YE, Wang H, Han S, Cen D, Zhang Z, Xiao K, Wang L, Wu X, Guo Q, Tao L, Li W, Shen X, Wu G.   +12 more
europepmc   +1 more source

Exploring the role of C1-inhibitor in thrombotic diseases. [PDF]

Blood Adv
Hansen JB.
europepmc   +1 more source

四肢静脈血栓症における血栓溶解療法の検討 : Urokinase投与に伴うFDPとPlasmin Inhibitorの変動を中心に

, 1979
Setsuo Takeuchi, Tadaaki SHIBA
openalex   +1 more source